Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|September 23, 2024

Vitiligo Insights: Case-Based Discussion on Delayed Treatment, Psychosocial Impact, and Evolving Approaches for SOC Patients

Author(s)Terry Faleye, MPAS, PA-C

Panelists discuss how vitiligo treatment delays, psychosocial effects, and emerging therapies impact standard of care for patients through case-based analysis.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Vitiligo Insights: Case-Based Discussion on Delayed Treatment, Psychosocial Impact, and Evolving Approaches for SOC Patients

1 KOL is featured in this series.

EP. 2 Case-Based Discussion on Adherence, Adjunctive Therapy, and Simplifying Complex Regimens for Patients With Vitiligo

1 KOL is featured in this series.

EP. 3 Exploring Phototherapy, Combination Therapy, and Patient-Centered Approaches to Improve QOL for Patients with Vitiligo

1 KOL is featured in this series.

EP. 4 Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management

1 KOL is featured in this series.

EP. 5 Exploring Efficacy, Novel Mechanisms, and Patient Engagement in the Management of Vitiligo

1 KOL is featured in this series.

EP. 6 Vitiligo Treatment Paradigms: Clinician Experiences with Topical Ruxolitinib and Access Challenges

1 KOL is featured in this series.

EP. 7 Optimizing Vitiligo Management: Key Takeaways on Treatment Cycling and Ruxolitinib Use

EP. 8 Improving Care and Innovations in Vitiligo and Atopic Dermatitis: Part 1

EP. 8 Improving Care and Innovations in Vitiligo and Atopic Dermatitis: Part 1

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Case 1: Choosing Non-Steroidal Topicals for Intertriginous Psoriasis

ByTina Bhutani-Jacques, MD

July 20th 2026

1 expert is featured in this series

The Ongoing Role of Topical Therapy in Plaque Psoriasis Management

ByTina Bhutani-Jacques, MD

July 20th 2026

2 experts are featured in this series

The Safety of Advanced Topical Therapies in Inflammatory Dermatoses

ByPeter Lio, MD,Alexandra K. Golant, MD

July 15th 2026

2 experts are featured in this series

Understanding Corticosteroid-Related Medical-Legal Risks in Inflammatory Dermatoses

ByPeter Lio, MD,Alexandra K. Golant, MD

July 15th 2026

Study Identifies Metabolic Pathway Linking Hyperglycemia to Vitiligo Progression

ByShannon Heaning, Content Associate

July 14th 2026

Latest CME

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis

New Consensus Defines Remission, Disease Activity in Atopic Dermatitis

Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites

Beyond Retinol: Evaluating the Stability, Safety, and Gene-Expression Profile of Bakuchiol Ferulate

AI-Assisted Imaging Tracks Success of Low-Fluence QSRL Laser for Melasma